Recently, Shandong-based functional sugar leader Bailong Chuangyuan (605016.SH) released its 2025 annual report, reporting dual growth: total operating income reached ~1.379 billion RMB (+19.75% YoY), and net profit attributable to parent hit ~369 million RMB (+50.06% YoY). The company plans to distribute a cash dividend of 1.65 RMB per 10 shares (before tax), with total dividends accounting for 30.20% of its net profit.
On the same day, Bailong Chuangyuan announced a 1.6 billion Thai baht (≈340 million RMB) capital increase for its Thai subsidiary, raising the latter’s registered capital from 600 million to 2.2 billion Thai baht (the company holds a 99.9999995% stake). The move aims to fund the "Thailand Smart Factory Project for New Health Food Ingredients," which is under construction and will ease the company’s production capacity shortage upon completion.
Overseas markets are key to Bailong Chuangyuan’s business, contributing 68.67% of its 2025 revenue (923 million RMB) with a 32.28% YoY growth and 47.82% gross profit margin—leading all regions. However, the company noted risks from U.S. tariff plans and global economic uncertainties.
Founded in 2005 and listed on the Shanghai Stock Exchange in 2021, Bailong Chuangyuan is a top global functional food ingredient manufacturer with over 200 product specifications, serving clients like Nestlé, Unilever and Wahaha. Its stock price rose 10.02% to 26.58 RMB after the annual report release, with an over 80% cumulative gain since its IPO.
Our Core Business
Prebiotics: FOS, GOS, XOS, IMO
Dietary Fiber: Resistant Dextrin, Polydetrose
Healthy Sweetners: D- Allulose, Crystalline Fructose, Isomaltulose, Isomalt